Data gathered: December 21
AI Stock Analysis - Astrazeneca (AZN)
Analysis generated November 27, 2024. Powered by Chat GPT.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company operates in various therapeutic areas, including oncology, cardiovascular, renal & metabolism, respiratory, and immunology. AstraZeneca has a strong presence in over 100 countries, and its innovative medicines are used by millions of patients worldwide.
Stock Alerts - Astrazeneca (AZN)
 |
Astrazeneca | November 5 Price is down by -7% in the last 24h. |
|
Astrazeneca | October 30 Price is down by -5.2% in the last 24h. |
|
Astrazeneca | October 14 AI Score is up by 21.6% in the last couple of days. |
|
Astrazeneca | August 31 Job postings are down by 51.2% in the last couple of days. |
Alternative Data for Astrazeneca
About Astrazeneca
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
| Price | $65.35 |
| Target Price | Sign up |
| Volume | 9,080,000 |
| Market Cap | $204B |
| Year Range | $63.2 - $87.62 |
| Dividend Yield | 2.3% |
| PE Ratio | 31.13 |
| Analyst Rating | 83% buy |
| Industry | Drug Manufacturers |
In the news
 |
ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZNDecember 20 - Investing.com |
AstraZeneca (AZN) Shares Fall After Reports of PRC Probe Alleged Fraud and Corruption – Hagens BermanDecember 19 - GlobeNewswire |
|
AstraZeneca PLC Announcement: If You Have Suffered Losses in AstraZeneca PLC (NASDAQ: AZN), You Are Encouraged to Contact The Rosen Law Firm About Your RightsDecember 18 - GlobeNewswire |
|
 |
Is AstraZeneca PLC (AZN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?December 17 - Yahoo Entertainment |
 |
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Verition Fund Management LLCDecember 14 - ETF Daily News |
 |
Analysts Set AstraZeneca PLC (LON:AZN) Target Price at £104.12December 13 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 13.6B | 3.08B | 10.5B | 1.43B | 4.1B | 0.457 |
| Q2 '24 | 12.9B | 3.15B | 9.79B | 1.93B | 4.12B | 0.990 |
| Q1 '24 | 12.9B | 3.15B | 9.79B | 1.93B | 4.13B | 1.030 |
| Q4 '23 | 12.7B | 3.14B | 9.54B | 2.18B | 4.57B | 0.730 |
| Q3 '23 | 11.5B | 2.1B | 9.4B | 1.37B | 3.34B | 0.870 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$144.47 0% | 40 |
 |
Eli Lilly and CompanyLLY |
$767.76 0% | 61 |
 |
PfizerPFE |
$26.36 0% | 37 |
 |
AbbVieABBV |
$175.58 0% | 60 |
 |
TherapeuticsMDTXMD |
$1.11 0% | 41 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Michael McCaul Republican |
Sep 20, 23 | Sell | $100K - $250K |
| Michael McCaul Republican |
Sep 20, 23 | Sell | $50K - $100K |
Read more about Astrazeneca (AZN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Astrazeneca?
The Market Cap of Astrazeneca is $204B.
What is Astrazeneca's PE Ratio?
As of today, Astrazeneca's PE (Price to Earnings) ratio is 31.13.
What is the current stock price of Astrazeneca?
Currently, the price of one share of Astrazeneca stock is $65.35.
How can I analyze the AZN stock price chart for investment decisions?
The AZN stock price chart above provides a comprehensive visual representation of Astrazeneca's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Astrazeneca shares. Our platform offers an up-to-date AZN stock price chart, along with technical data analysis and alternative data insights.
Does AZN offer dividends to its shareholders?
Yes, Astrazeneca (AZN) offers dividends to its shareholders, with a dividend yield of 2.3%. This dividend yield represents Astrazeneca's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Astrazeneca in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Astrazeneca?
Some of the similar stocks of Astrazeneca are Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie, and TherapeuticsMD.
.